I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| non-classical monocyte | 14 studies | 32% ± 18% | |
| fibroblast | 9 studies | 22% ± 7% | |
| endothelial cell | 8 studies | 22% ± 6% | |
| natural killer cell | 8 studies | 19% ± 4% | |
| CD16-positive, CD56-dim natural killer cell, human | 7 studies | 21% ± 6% | |
| classical monocyte | 7 studies | 26% ± 11% | |
| epithelial cell | 6 studies | 26% ± 8% | |
| neuron | 4 studies | 27% ± 12% | |
| retinal ganglion cell | 4 studies | 46% ± 26% | |
| pericyte | 4 studies | 19% ± 3% | |
| astrocyte | 4 studies | 21% ± 4% | |
| glutamatergic neuron | 4 studies | 40% ± 21% | |
| oligodendrocyte | 4 studies | 18% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 21% ± 4% | |
| myofibroblast cell | 3 studies | 17% ± 1% | |
| ciliated cell | 3 studies | 25% ± 8% | |
| GABAergic neuron | 3 studies | 38% ± 13% | |
| monocyte | 3 studies | 19% ± 2% | |
| macrophage | 3 studies | 19% ± 3% | |
| basal cell | 3 studies | 22% ± 2% |
